Hernia graft study halted early – what we know
NCT ID NCT04294446
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at the Biodesign Hernia Graft, a device made from pig intestinal tissue, used to strengthen the abdominal wall during ventral hernia repair. It enrolled 74 adults needing surgery for a primary or recurrent hernia. The goal was to track hernia recurrence and side effects like infection over two years. However, the study was terminated early, so the full picture is limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Biodesign Hernia Graft (a device made from pig intestinal tissue to reinforce hernia repair)
What this could lead to
If successful, this could confirm the graft is safe and effective for routine use in ventral hernia repair.
What could go wrong
The study was terminated early, so results may be incomplete. Hernia recurrence and complications like infection remain possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTRAL HERNIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Queen Elizabeth II Hospital
Halifax, Nova Scotia, B3H 2Y9, Canada
-
St. Paul's Hospital
Vancouver, British Columbia, V6Z 1Y6, Canada
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States